{
    "nct_id": "NCT03535701",
    "official_title": "Ketogenic Diet and Chemotherapy to Affect Recurrence of Breast Cancer (The KETO-CARE Study)",
    "inclusion_criteria": "* Body mass index (BMI) >= 22 kg/m^2\n* Confirmed diagnosis of metastatic or stage IV BC\n* Fludeoxyglucose F-18 (FDG)-positron emission tomography (PET) avid tumors\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 (0=participant has either normal activity, 1= participant has some symptoms but is nearly full ambulatory)\n* Life expectancy > 6 months\n* Able and willing to follow prescribed diet intervention\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior chemotherapy for metastatic breast cancer (MBC) (prior adjuvant chemotherapy permitted as long as > 12 months [mo])\n* BMI < 25 kg/m^2\n* Weight change > 5% within 3 months of enrollment\n* Type 1 diabetes\n* History of diabetes with retinopathy requiring treatment\n* Current use of insulin or sulfonylureads for glycemic control, or history of ketoacidosis\n* Intestinal obstruction\n* Bilirubin > 2\n* Albumin < 3.5\n* Glomerular filtration rate (GFR) < 55 mL/min\n* Creatinine > 2.0\n* Urinary albumin > 1 g/day\n* Congestive heart failure\n* Pregnant or nursing women\n* Unable to provide informed consent\n* Uncontrolled concurrent medical conditions that would limit compliance with study requirements",
    "miscellaneous_criteria": ""
}